NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM7119707 Query DataSets for GSM7119707
Status Public on Sep 22, 2023
Title prostate cancer patient pre-treatment serum EV, DODEV12
Sample type RNA
 
Source name peripheral venous source
Organism Homo sapiens
Characteristics patient id: DOD12
disease state: prostate cancer
tissue: serum
sample type: serum EVs
ap: 1
grade of prostate cancer at biopsy: high-grade (1)
capra risk: INTERMEDIATE
capra score: 3
fraction: microRNA
Treatment protocol n/a
Growth protocol n/a
Extracted molecule total RNA
Extraction protocol Total RNA was extracted with the miRNeasy Serum/Plasma kit (Qiagen).
Label SYBR Green
Label protocol PCR assay were performed using a miRCURY LNA miRNA Custom PCR Panel Catalog#YCA25430 (Qiagen) following the manufacturers instructions. Reverse transcription was performed from 5ยต L total RNA using the miRCURY LNA RT Kit (Qiagen). Quantitative real-time PCR were performed (Applied Biosystems ViiA 7) with 40 cycles at 95C for 10 seconds and 56C for 60 seconds.
 
Hybridization protocol n/a
Scan protocol n/a
Data processing The raw data (raw CT) values were input into GeneGlobe with a CT cutoff value of 33. In the GeneGlobe preprocessing, all CTs greater than 33 were changed to a value of 33 and the CTs were adjusted for the interplate calibrator (UniSp3) according to the miRCURY LNA miRNA PCR Panels & Assays Data Analysis Handbook.
Normalization values for each sample were calculated using the NormFinder method in GeneGlobe. The microRNAs used for normalization of serum samples included: miR-107, miR-24-3p, let-7i-5p, miR-19b-3p, miR-16-5p, miR-320a, miR-23a-3p, miR-21-5p, let-7b-5p, and miR-25-3p. The microRNAs included for normalization of serum EV samples included: included hsa-miR-107, hsa-miR-24-3p, hsa-miR-30c-5p, hsa-miR-93-5p, hsa-let-7i-5p, hsa-miR-222-3p, hsa-miR-27a-3p, hsa-miR-23a-3p, hsa-miR-21-5p, and hsa-miR-27b-3p.
These normalized values were then used to make comparisons between groups (adverse pathology versus not adverse pathology) to determine significantly different microRNAs using p < 0.05
The significant microRNAs were then used to generate random forest models to predict adverse pathology
The Fold Change Template shows the p-values for each microRNA. The microRNAs with p<0.05 were included in the random forest model to predict adverse pathology.
 
Submission date Mar 28, 2023
Last update date Sep 22, 2023
Contact name Morgan Zenner
E-mail(s) zenner2@uic.edu
Phone 8473728777
Organization name University of Illinois at Chicago College of Medicine
Department Pathology
Lab Larisa Nonn
Street address 909 South Wolcott Ave
City Chicago
State/province IL
ZIP/Postal code 60612
Country USA
 
Platform ID GPL33285
Series (1)
GSE228371 Real-time quantitative PCR analysis of pre-treatment serum microRNAs from patients with prostate cancer

Data table header descriptions
ID_REF
VALUE Normalized values

Data table
ID_REF VALUE
hsa-let-7a-5p -0.343243332
hsa-miR-100-5p -6.595350952
hsa-miR-103a-3p 0.276774673
hsa-miR-106a-5p -0.106072159
hsa-miR-107 0.038211136
hsa-miR-130b-3p -4.508442612
hsa-miR-146a-5p -0.912956924
hsa-miR-223-3p 4.385083466
hsa-miR-24-3p 1.26625946
hsa-miR-26b-5p -2.610035629
hsa-miR-30c-5p -1.556423874
hsa-miR-451a 6.457307129
hsa-miR-874-3p -4.684841843
hsa-miR-93-5p 0.548703461
hsa-let-7i-5p -0.349518509
hsa-miR-1246 -0.084700317
hsa-miR-18b-5p -4.0258815
hsa-miR-19b-3p 1.54061058
hsa-miR-194-5p -3.486880035
hsa-miR-204-5p -5.830378265

Total number of rows: 50

Table truncated, full table size 1 Kbytes.




Supplementary data files not provided
Processed data included within Sample table
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap